PT Siloam International Hospitals Tbk
Bear Case (25th pct.)
-48.5% vs price
Base Case (Median)
-16.1% vs price
Bull Case (75th pct.)
-8.0% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $43.93 | -98.1% | High (40%) |
| PE Comparable | $1954.87 | -16.1% | Medium (25%) |
| Growth Trajectory DCF | $3325.21 | 42.7% | Medium (20%) |
| Graham Number | $1217.71 | -47.7% | Medium (40%) |
| EV/EBITDA | $2076.10 | -10.9% | Medium (20%) |
| EV/FCF | $1183.11 | -49.2% | Medium (20%) |
| Earnings Power Value | $2210.11 | -5.1% | Medium (50%) |
Based on 7 out of 8 methods, SILO.JK appears overvalued at the current price of $2330.00. The base case fair value of $1954.87 implies 16.1% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.